Peptido Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is LIOTHYRONINE SODIUM, with a corresponding US DMF Number 19467.
Remarkably, this DMF maintains an Active status since its submission on May 19, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 10, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II